PT97192A - Sistema de libertacao controlada transdermal - Google Patents

Sistema de libertacao controlada transdermal

Info

Publication number: PT97192A
Authority: PT; Portugal
Prior art keywords: addition; active substance; cyclic compound; release; controlled
Prior art date: 1991-03-28

Application number

PT9719291A

Other languages

English (en)

Other versions

PT97192B (pt

Inventor

Jens Hansen

Brigitte Mollgaard

Original Assignee

Kabi Pharmacia Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-03-28

Filing date

1991-03-28

Publication date

1992-09-30

1991-03-28 Application filed by Kabi Pharmacia Ab filed Critical Kabi Pharmacia Ab

1991-03-28 Priority to PT9719291A priority Critical patent/PT97192B/pt

1992-09-30 Publication of PT97192A publication Critical patent/PT97192A/pt

1998-11-30 Publication of PT97192B publication Critical patent/PT97192B/pt

Links

238000013270 controlled release Methods 0.000 title abstract 2
239000013543 active substance Substances 0.000 abstract 5
150000001923 cyclic compounds Chemical class 0.000 abstract 4
238000010494 dissociation reaction Methods 0.000 abstract 2
230000005593 dissociations Effects 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 1
239000003002 pH adjusting agent Substances 0.000 abstract 1
239000002904 solvent Substances 0.000 abstract 1

Landscapes

Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PT9719291A 1991-03-28 1991-03-28 Sistema de libertacao controlada transdermal PT97192B (pt)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
PT9719291A PT97192B (pt)	1991-03-28	1991-03-28	Sistema de libertacao controlada transdermal

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PT9719291A PT97192B (pt)	1991-03-28	1991-03-28	Sistema de libertacao controlada transdermal

Publications (2)

Publication Number	Publication Date
PT97192A true PT97192A (pt)	1992-09-30
PT97192B PT97192B (pt)	1998-11-30

Family

ID=20084914

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT9719291A PT97192B (pt)	1991-03-28	1991-03-28	Sistema de libertacao controlada transdermal

Country Status (1)

Country	Link
PT (1)	PT97192B (pt)

1991
- 1991-03-28 PT PT9719291A patent/PT97192B/pt not_active IP Right Cessation

Also Published As

Publication number	Publication date
PT97192B (pt)	1998-11-30

Similar Documents

Publication	Publication Date	Title
ATE137405T1 (de)	1996-05-15	Transdermales system
HU900108D0 (en)	1990-03-28	Composition of controlled active ingredient delivery, operating by hydrogel
CA2010218A1 (en)	1990-08-18	Therapeutic system for the retarded and controlled transdermal or transmucous administration of active substances
MY103355A (en)	1993-06-30	Active substance-containing plaster of the controlled administration of active substances to the skin, the use thereof and a process for the controlled administration of active substances to the skin
DK0609961T3 (da)	1999-04-06	Farmaceutisk præparat med langvarig frigivelse
ATE164063T1 (de)	1998-04-15	Thyroaktive zusammensetzung mit kontrollierter freigabe
DE3486409D1 (de)	1995-11-16	Zusammensetzung zur kontrollierten Abgabe eines Wirkstoffs.
ATE176398T1 (de)	1999-02-15	Morphinzubereitungen mit kontrollierter freisetzung
KR880010768A (ko)	1988-10-24	위장장해의 치료 및 예방용 약제학적 조성물
ATE117199T1 (de)	1995-02-15	Reaktionsdotierte brausesysteme.
DE3577851D1 (de)	1990-06-28	Inositoltriphosphat, verfahren zu seiner herstellung und dieses enthaltende zubereitung.
DK581685A (da)	1986-06-18	Transderimalt system for timolol-indgift
HUT50624A (en)	1990-03-28	Process for producing pharmaceuical compositions with controlled release of active ingredient
DE3789576D1 (de)	1994-05-19	Verwendung von Inositol-Triphosphat zur Behandlung von Metallvergiftung.
HU9802889D0 (en)	1999-02-01	Percutaneous absorption type preparation
DE60100994D1 (de)	2003-11-20	Transdermales therapeutisches System für die Erzielung hoher Plasmaspiegel von Rotigotin in der Therapie von Morbus Parkinson
DE59410151D1 (de)	2002-08-14	Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
TR199700711T1 (xx)	1998-01-21	Ciltten ge�erek v�cuda giren form�lasyon.
CA2219406A1 (en)	1996-12-12	Device for transdermal electrotransport delivery of fentanyl and sufentanil
ATE81288T1 (de)	1992-10-15	Verkapselung von trh bzw. dessen analoga.
SE8303003L (sv)	1983-11-29	Medel for att oka antitumorverkan hos antitumormedel
PT97192A (pt)	1992-09-30	Sistema de libertacao controlada transdermal
ITRM910730A1 (it)	1993-03-30	Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali.
ATE87476T1 (de)	1993-04-15	Fluessige orale formulierung.
FI883988A7 (fi)	1989-03-01	Glysidoksipropyylisilanolin ja polydimetyylisiloksaanien käyttö ja niitä sisältävät vesipitoiset irrotusaineet.

Legal Events

Date	Code	Title	Description
1992-09-30	BB1A	Laying open of patent application	Effective date: 19910724
1998-11-30	FG3A	Patent granted, date of granting	Effective date: 19980820
2007-09-21	PD4A	Change of proprietorship	Owner name: PFIZER HEALTH AB, SE Effective date: 20070910 Owner name: PHARMACIA AB, SE Effective date: 20070910
2007-11-28	PC4A	Transfer of assignment	Owner name: MCNEIL AB, SE Effective date: 20071102
2009-03-03	MM4A	Annulment/lapse due to non-payment of fees;searched & examined patent	Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 20090220